Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription 19.05.2025 4 BMC Cancer 7 Br J Dermatol 2 Cancer 1 Cancer Lett 3 Cancer Res 3 Clin Dermatol 9 Clin Exp Dermatol 4 Int J Cancer 9 Int J Dermatol 2 J Cutan Pathol 5 J Dermatol 5 J Invest Dermatol 1 Lancet 1 Nat Rev Cancer 12 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. LU Y, Shi Z, Zhao Q, Bi Z, et al
   Exploring the clinical value of regional nodal irradiation in sentinel lymph node positive breast cancer patients omitting axillary dissection.
   BMC Cancer. 2025;25:866.
   PubMed         Abstract available
   
   
2. ZARGARANI N, Kavousi M, Aliasgari E
   A potential new strategy for BC treatment: NPs containing solanine and evaluation of its anticancer and antimetastatic properties.
   BMC Cancer. 2025;25:860.
   PubMed         Abstract available
   
   
3. BROWN C, Kang HA, Johnsrud M, Terry J, et al
   Assessing equity of care across metastatic breast cancer treatment junctures: a multi-site retrospective cohort study.
   BMC Cancer. 2025;25:861.
   PubMed         Abstract available
   
   
4. SANGERS TE, Wakkee M, Moolenburgh F, Nijsten T, et al
   Mobile health apps for skin cancer triage in the general population: a qualitative study on healthcare providers' perspectives.
   BMC Cancer. 2025;25:851.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

5. WANG Y, Xu G, Xia H
   Targeting the MAPK Pathway for NRAS Mutant Melanoma: From Mechanism to Clinic.
   Br J Dermatol. 2025 May 9:ljaf178. doi: 10.1093.
   PubMed         Abstract available
   
   
6. YANG HW, Chen YH, To SY, Wen YL, et al
   Hormone Therapy and Increased Risk of Psoriasis in Reproductive-age and Postmenopausal Women: A Nationwide Cohort Study and Target Trial Emulation.
   Br J Dermatol. 2025 May 9:ljaf179. doi: 10.1093.
   PubMed         Abstract available
   
   
7. ARMSTRONG AW, Blauvelt A, Lebwohl M, Asahina A, et al
   Efficacy and safety of tildrakizumab in patients with early- vs late-onset psoriasis.
   Br J Dermatol. 2025 May 14:ljaf171. doi: 10.1093.
   PubMed         Abstract available
   
   
8. CHEN JQ, Zheng M, Yin WH, Wang P, et al
   Safety and efficacy of the selective TYK2/JAK1 inhibitor TLL-018 in moderate-to-severe plaque psoriasis: A phase 1b, randomized, double-blind, placebo-controlled study.
   Br J Dermatol. 2025 May 14:ljaf185. doi: 10.1093.
   PubMed         Abstract available
   
   
9. DOELEMAN T, Beljaards ESM, Ottevanger R, Jansen P, et al
   Added value of pathology consultations in cutaneous lymphomas: a 2-year review from the Dutch national referral and expertise centre.
   Br J Dermatol. 2025 May 14:ljaf184. doi: 10.1093.
   PubMed         Abstract available
   
   
10. DA ROSA GP, Santos JV, Cerejeira A, Matos P, et al
    Patterns of hospitalizations due to bacterial skin and soft tissue infections: a retrospective observational study from a Portuguese national registry.
    Br J Dermatol. 2025 May 15:ljaf157. doi: 10.1093.
    PubMed        
    
    
11. POWELL JB, Dhesi JK, Harwood CA, McGrath EJ, et al
    How do we avoid over-treating skin cancer in people with severe frailty and limited life expectancy?
    Br J Dermatol. 2025 May 15:ljaf174. doi: 10.1093.
    PubMed        
    
    

    
    Cancer

12. ZHANG H, Charlton BM, Schnarrs PW, Trentham-Dietz A, et al
    Mammography screening and risk factor prevalence by sexual identity: A comparison of two national surveys.
    Cancer. 2025;131:e35852.
    PubMed         Abstract available
    
    
13. YEN TWF, Nattinger AB, Bickell NA, Schymura MJ, et al
    Does regionalization of initial breast cancer care delay time to surgery?
    Cancer. 2025;131:e35895.
    PubMed         Abstract available
    
    

    
    Cancer Lett

14. RUPP B, Nagpal N, Thanasiu B, Tuck K, et al
    Multiplex characterization of circulating tumor cells from ductal carcinoma in situ patients suggests early tumor dissemination.
    Cancer Lett. 2025;623:217703.
    PubMed         Abstract available
    
    

    
    Cancer Res

15. GOHARI Z, Stojanovic L, Rassool FV
    Combining STING Agonists with PARP Inhibitors Mounts an NK-Dependent Defense against Therapy-Resistant Breast Cancer.
    Cancer Res. 2025;85:1747-1749.
    PubMed         Abstract available
    
    
16. PEDRETTI F, Abdalfttah M, Pellegrino B, Mateo F, et al
    Harnessing STING Signaling and Natural Killer Cells overcomes PARP Inhibitor Resistance in Homologous Recombination Deficient Breast Cancer.
    Cancer Res. 2025 Mar 11. doi: 10.1158/0008-5472.CAN-24-2531.
    PubMed         Abstract available
    
    
17. SUN Z, Li Z, Wei Y, Xu L, et al
    SMARCA4 Inhibits Breast Cancer Progression and Metastasis through RHOA Suppression.
    Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-2801.
    PubMed         Abstract available
    
    

    
    Clin Dermatol

18. GOPAL J, Zhou AE, Marghoob AA, Gronbeck C, et al
    The State of AI-Enabled Skin Cancer Diagnostics: Why Are There Two Spectroscopy Devices Available Yet No Imaging Devices?
    Clin Dermatol. 2025 May 7:S0738-081X(25)00141.
    PubMed         Abstract available
    
    
19. HAYKAL D, Berardesca E, Kabashima K, Dreno B, et al
    Beyond Beauty: Neurocosmetics, the Skin-Brain Axis, and the Future of Emotionally Intelligent Skincare.
    Clin Dermatol. 2025 May 10:S0738-081X(25)00142.
    PubMed         Abstract available
    
    
20. SANCHEZ-ANGUIANO ME, Jarquin JCZ, Ledesma Y, Maverakis E, et al
    Dermatology Disparities and Skin Cancer Risk Factors Experienced by Rural Latine Patients: A Survey Study at a Single Academic Institution.
    Clin Dermatol. 2025 May 12:S0738-081X(25)00156.
    PubMed        
    
    

    
    Clin Exp Dermatol

21. FINNEGAN P, Lightner C, Clover J, Heffron C, et al
    A mimicker of melanoma on sun-exposed sites.
    Clin Exp Dermatol. 2025 May 12:llaf199. doi: 10.1093.
    PubMed        
    
    
22. HONG S, Quon J, Nelson CA
    Mental Health and Psychosocial Outcomes in Survivors of Severe Cutaneous Adverse Reactions: A Scoping Review.
    Clin Exp Dermatol. 2025 May 12:llaf202. doi: 10.1093.
    PubMed         Abstract available
    
    
23. OGBUTOR C, Chen LC, Kelley KJ, Senna MM, et al
    Uterine and ovarian pathologies among patients with lichen planopilaris and frontal fibrosing alopecia.
    Clin Exp Dermatol. 2025 May 14:llaf210. doi: 10.1093.
    PubMed        
    
    
24. 
    Correction to: The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).
    Clin Exp Dermatol. 2025 May 15:llaf175. doi: 10.1093.
    PubMed        
    
    
25. DIAZ MJ, Tran JT, Gan RQ
    Predictors for TNFi-induced paradoxical psoriasis in rheumatoid arthritis patients: an exploratory analysis informed by cross-validated random forest.
    Clin Exp Dermatol. 2025 May 16:llaf223. doi: 10.1093.
    PubMed        
    
    
26. DAVIES W
    The importance of cardiac screening in X-linked ichthyosis - a plea.
    Clin Exp Dermatol. 2025 May 16:llaf221. doi: 10.1093.
    PubMed        
    
    
27. ANDREW K, Li D, Emmanuel NS, Shim TN, et al
    Developing a Genital Disease Quality of Life Index Questionnaire for Male Genital Lichen Sclerosus: A Modification of the Vulvar Quality of Life Index (VQLI) - A Pilot Study.
    Clin Exp Dermatol. 2025 May 16:llaf219. doi: 10.1093.
    PubMed        
    
    
28. UFODIAMA CE, Lada G, Griffiths TW, Kleyn CE, et al
    Acne Vulgaris: Considerations in darker skin types.
    Clin Exp Dermatol. 2025 May 16:llaf220. doi: 10.1093.
    PubMed        
    
    
29. CAUSSSADE MC, Aguero R, Donoso F, Alsheik H, et al
    Vulvar basal cell carcinoma treated with Mohs micrographic surgery: A case series and systematic review.
    Clin Exp Dermatol. 2025 May 16:llaf203. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Cancer

30. CIVITA P, Mazzanti CM, Lessi F, Marchio C, et al
    Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus.
    Int J Cancer. 2025;157:371-383.
    PubMed         Abstract available
    
    
31. HUANG T, Wu D, Jiang L, Wu Z, et al
    Neuro-astrocytic network in breast cancer brain metastases: Adaptive mechanisms and novel therapeutic targets.
    Int J Cancer. 2025 Apr 1. doi: 10.1002/ijc.35421.
    PubMed         Abstract available
    
    
32. LU W, Yao L, Wang Y, Li F, et al
    Characterization of extrachromosomal circular DNA associated with genomic repeat sequences in breast cancer.
    Int J Cancer. 2025 Mar 26. doi: 10.1002/ijc.35423.
    PubMed         Abstract available
    
    
33. JALAGUIER S, Kuehn A, Petitpas C, Dulom A, et al
    The transcription factor RIP140 regulates interferon gamma signaling in breast cancer.
    Int J Cancer. 2025 Mar 10. doi: 10.1002/ijc.35405.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

34. JING F, Pazhava A, Shachaf C, Meves A, et al
    The Role of Stromal Tumor Environment in Advancing Skin Cancer Diagnosis and Treatment.
    Int J Dermatol. 2025 May 14. doi: 10.1111/ijd.17827.
    PubMed         Abstract available
    
    
35. ZHANG Q, Wang X
    Cutaneous Collagenous Vasculopathy With Unilateral Facial Involvement: A Rare Variant.
    Int J Dermatol. 2025 May 14. doi: 10.1111/ijd.17856.
    PubMed        
    
    
36. BUENO-MOLINA RC, Sendin-Martin M, Hernandez-Rodriguez JC, Cayuela L, et al
    Geospatial Analysis of Cutaneous Malignant Melanoma Epidemiology in Europe From 2017 to 2021.
    Int J Dermatol. 2025 May 14. doi: 10.1111/ijd.17851.
    PubMed         Abstract available
    
    
37. KOUMPRENTZIOTIS IA, Niforou A, Tsimpidakis A, Nikolaou C, et al
    Dupilumab for the Treatment of Cutaneous Immune-Related Adverse Events: A Systematic Review.
    Int J Dermatol. 2025 May 15. doi: 10.1111/ijd.17850.
    PubMed         Abstract available
    
    
38. RIVA HR, Sohail N, Shalabi MMK, Kelley B, et al
    Surgical treatment of pilomatrix carcinoma: a systematic review.
    Int J Dermatol. 2025;64:1021-1026.
    PubMed         Abstract available
    
    
39. SCHEINKMAN R, Gwillim E, Barbota K, Tordjman L, et al
    The Dermatology of Recreational Scuba Diving: A Narrative Review.
    Int J Dermatol. 2025;64:1005-1012.
    PubMed         Abstract available
    
    
40. SASI G, Divya KS, Patnala G, Karri SB, et al
    Blaschkoid Alopecia.
    Int J Dermatol. 2025;64:975-977.
    PubMed         Abstract available
    
    
41. CHOVATIYA R, Hawkes JE, DiRuggiero D, Pansch LA, et al
    Type 2 Inflammation and Its Role in Dermatologic Diseases.
    Int J Dermatol. 2025;64:978-991.
    PubMed         Abstract available
    
    
42. KEMENY L
    Editor's Highlights-June 2025.
    Int J Dermatol. 2025;64:967-968.
    PubMed         Abstract available
    
    

    
    J Cutan Pathol

43. LANEHART MH, Bertus B, Bacaj PJ, Kolodney MS, et al
    Clinicopathologic Features of Penile Ulceration in Malignant Atrophic Papulosis: A Case Report and Review of the Literature.
    J Cutan Pathol. 2025;52:423-427.
    PubMed         Abstract available
    
    
44. HABERECHT HB, Ziebart RL, Iverson OC, Todd A, et al
    Histopathologic Features in Vancomycin-Associated Drug-Induced Hypersensitivity Syndrome.
    J Cutan Pathol. 2025;52:442-451.
    PubMed         Abstract available
    
    

    
    J Dermatol

45. JIA DD, Xu Y, Ren ZW, Li LQ, et al
    Is One Year Enough? Extended Adjuvant Dabrafenib Plus Trametinib for Chinese Patients With Resected Stage III Melanoma.
    J Dermatol. 2025 May 14. doi: 10.1111/1346-8138.17779.
    PubMed         Abstract available
    
    
46. IWATA Y, Saito K, Matsushima J, Sugiura K, et al
    Generalized Pustular Psoriasis-Like Eruption Triggered by a G-CSF-Producing Lung Adenocarcinoma.
    J Dermatol. 2025 May 9. doi: 10.1111/1346-8138.17780.
    PubMed        
    
    
47. OHTSUKI M, Okubo Y, Saeki H, Igarashi A, et al
    Clinical Characteristics and Safety Profiles of Japanese Psoriasis Patients Who Continued Apremilast Treatment for 6 and 12 Months: A Post Hoc Analysis of an Apremilast Postmarketing Surveillance Study.
    J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17764.
    PubMed         Abstract available
    
    
48. TSUBOI S, Yatsuzuka K, Kohri N, Yoshida S, et al
    Severe Exacerbation of Psoriasis Vulgaris With Topical Imiquimod Therapy: A Case Report.
    J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17782.
    PubMed        
    
    
49. NISHIMURA K, Kimura A, Nakamura A, Takatsuka S, et al
    Impact of Surgical Delay on Prognosis in Patients With Cutaneous Melanoma: A Single-Institution Retrospective Study in Japan.
    J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17773.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

50. KOTKOWSKA ZK, Haunerdinger V, Waeckerle-Men Y, Kolm-Djamei I, et al
    Inflammatory cutaneous reactions with systemic CD8(+) T-cell responses upon photochemical internalization of antigens in mice.
    J Invest Dermatol. 2025 May 8:S0022-202X(25)00467.
    PubMed         Abstract available
    
    
51. RICCI LARA MA, Frutos EL, Rodriguez Kowalczuk MV, Ferraresso MG, et al
    External Validation of an AI Ensemble for Skin Cancer Detection: Enhancing Diagnostic Performance on Dermoscopic Images.
    J Invest Dermatol. 2025 May 9:S0022-202X(25)00469.
    PubMed        
    
    
52. FOWLER EA, Sacramento LA, Bowman BA, Lee B, et al
    Hypoxia and IL-15 cooperate to induce perforin expression by CD8 T cells and promote damage to the skin in murine cutaneous leishmaniasis.
    J Invest Dermatol. 2025 May 13:S0022-202X(25)00479.
    PubMed         Abstract available
    
    
53. PATRA V, Trajanoski S, Joshi A, Lenief V, et al
    Urocanase-positive skin resident bacteria metabolize cis-urocanic acid and in turn reduce the immunosuppressive properties of UV radiation.
    J Invest Dermatol. 2025 Apr 21:S0022-202X(25)00405.
    PubMed         Abstract available
    
    
54. POLO-SILVEIRA L, Dusza SW, Kentley J, Marchetti MA, et al
    Cutaneous Melanoma Risk Assessment Among Individuals with a High-Risk Nevus Phenotype.
    J Invest Dermatol. 2025 May 13:S0022-202X(25)00478.
    PubMed        
    
    

    
    Lancet

55. GIMENEZ-ARNAU AM, Pinter A, Sondermann W, Reguiai Z, et al
    Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial.
    Lancet. 2025;405:1676-1688.
    PubMed         Abstract available
    
    

    
    Nat Rev Cancer

56. BREWER G
    Ageing lipids map melanoma's journey.
    Nat Rev Cancer. 2025 May 15. doi: 10.1038/s41568-025-00833.
    PubMed        
    
    

    
    PLoS One

57. RABBANI B, Tanu SG, Ramanto KN, Audrienna J, et al
    A combined risk model shows viability for personalized breast cancer risk assessment in the Indonesian population: A case/control study.
    PLoS One. 2025;20:e0321545.
    PubMed         Abstract available
    
    
58. ZHANG L, Gao X, He M, Wang W, et al
    Nonlinear association between C-reactive protein and severity of diabetic foot infection in patients with diabetes: A retrospective cohort study with clinical implications.
    PLoS One. 2025;20:e0323704.
    PubMed         Abstract available
    
    
59. BRAR HK, Chen E, Chang F, Lu SA, et al
    Leishmania regulates host YY1: Comparative proteomic analysis identifies infection modulated YY1 dependent proteins.
    PLoS One. 2025;20:e0323227.
    PubMed         Abstract available
    
    
60. COSTELA-RUIZ VJ, Gonzalez-Vigil E, Espinosa-Ibanez O, Alcazar-Caballero RM, et al
    Application of allogeneic adult mesenchymal stem cells in the treatment of venous ulcers: A phase I/II randomized controlled trial protocol.
    PLoS One. 2025;20:e0323173.
    PubMed         Abstract available
    
    
61. KHOSROWZADEH N, Saini AS, Samimi K, Chambers K, et al
    Disparities in physician compensation for breast and prostate cancer operations.
    PLoS One. 2025;20:e0323892.
    PubMed         Abstract available
    
    
62. WU WP, Lin J, Huang YL, Chen ST, et al
    Magnetic resonance imaging characteristics and survival outcomes of metaplastic breast carcinoma.
    PLoS One. 2025;20:e0323541.
    PubMed         Abstract available
    
    
63. WANG C, Wu Q, Chen J, Wang J, et al
    Mechanistic role of pyroptosis in Kawasaki disease: An integrative bioinformatics analysis of immune dysregulation, machine learning-based biomarker discovery, WGCNA, and drug repurposing insights.
    PLoS One. 2025;20:e0323597.
    PubMed         Abstract available
    
    
64. AZMI MB, Yu H, Sohail A, Asif U, et al
    In silico analysis to explore the therapeutic potential of propolis-derived small molecules as matriptase inhibitors to suppress breast cancer growth and metastasis.
    PLoS One. 2025;20:e0321687.
    PubMed         Abstract available
    
    
65. PRADO-CELIS LP, Zamora-Cardenas R, Alamilla J, Sanchez-Pastor EA, et al
    Nucleolar sequestration of cannabinoid type-2 receptors in triple-negative breast cancer cells.
    PLoS One. 2025;20:e0323554.
    PubMed         Abstract available
    
    
66. RANES JMC, Moore JL, Patterson NH, Nicholson SP, et al
    MALDI imaging mass spectrometry differentiates basal cell carcinoma from trichoblastoma and trichoepithelioma: A proof of principle study.
    PLoS One. 2025;20:e0323475.
    PubMed         Abstract available
    
    
67. KINTEH B, Jitteh F, Badjie M, Barrow A, et al
    Exploring breast cancer awareness and screening practices amongst rural women in The Gambia: Community-based cross-sectional study.
    PLoS One. 2025;20:e0307785.
    PubMed         Abstract available
    
    
68. CHEN C, Gao D, Yue H, Wang H, et al
    Predicting breast cancer prognosis based on a novel pathomics model through CHEK1 expression analysis using machine learning algorithms.
    PLoS One. 2025;20:e0321717.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.